Late stages of the Zika virus life cycle are impaired by a selective TRPML2 agonist
Kerstin K. Schwickert, Mirco Glitscher, Daniela Bender, Robin Murra, Kevin Schwickert, Steffen Pfalzgraf, Tanja Schirmeister, Ute A. Hellmich, Eberhard Hildt
This study shows that the TRPML2 agonist ML2-SA1 inhibits late stages of Zika virus replication by affecting genome replication and intracellular cholesterol distribution.
bioRxiv · Feb 1, 2024 · PreprintCell Biology